Do Peanuts Raise Blood Sugar? Hardly, in Glycemic Index Tests and 8 Trials

“Do peanuts raise blood sugar” is searched about 720 times a month in the United States (from a paid keyword database, pulled 20 October 2026) [1]. The question gets two loud answers. One, in a diabetes forum thread that Google’s AI answer cites, is titled “anyone know why peanuts spike blood sugar”. The other comes from the peanut industry itself: peanuts and peanut butter “don’t cause blood glucose to spike” and are “like a secret weapon” for people with diabetes, in the words of the industry’s promotion board [1].

Hardly. Eaten on their own, peanuts move blood sugar very little, and over weeks of eating them, fasting blood sugar came out about even with the comparison diets. In the published tests, the rise in blood sugar after peanuts averaged about a seventh of the rise after the same carbohydrate as plain glucose [2] [3]. In eight randomised trials pooled in 2022, fasting blood sugar with peanuts averaged about 0.5 mg/dL higher than on the comparison diets, with a range that includes no difference at all [4]. What can change the answer is what comes with the peanuts, in the jar or on the plate, and that is covered below.

This is journalism, not medical advice. If you have diabetes or prediabetes, plan changes to what you eat with your clinician or dietitian, who knows your medicines and your numbers.

What is the glycemic index of peanuts?

The glycemic index scores how far a food raises blood sugar over two hours, against the same amount of carbohydrate eaten as plain glucose, which scores 100 [2]. It compares portions holding the same carbohydrate, not the same handful, as our oatmeal verdict explains. A score of 55 or less counts as low [5].

The figure everyone quotes for peanuts, “around 13 to 14”, traces to three small tests. The first, in 1981, gave 5 healthy volunteers enough peanuts to supply 25 g of carbohydrate; their blood sugar rose 13% as much as it did after glucose [2]. Peanuts hold little carbohydrate that is not fibre, about 4 to 7 g in 1.8 oz (50 g) by the tables’ figures [3] [6], so supplying 25 g of it took about 6.3 oz (about 180 g) of peanuts even at the higher figure, by our arithmetic; the paper notes that some volunteers found the peanuts hard to finish [2]. A test of crushed peanuts in South Africa came out at 7, and one in Mexico at 23; the 2002 international tables averaged the three to 14 [3].

The glycemic index of peanuts, every published test we found
TestWho ate the peanutsGlycemic index (glucose = 100)
Canada and England, 1981 [2]5 healthy volunteers13
South Africa, crushed peanuts [3]6 healthy volunteers7
Mexico [3]21 healthy volunteers and 27 with type 2 diabetes23
The 2002 tables’ average of the three [3]14
Philippines, boiled peanuts [5]Volunteers with and without type 2 diabetes5 and 7
For comparison: white bread, average of 16 tests [6]75
A glycemic index of 55 or less counts as low. The 2008 tables keep the South African test in their main table and move the Canadian and Mexican ones to a second table, for values from small numbers of people or showing wide variability; the University of Sydney’s database marks every peanut value that way. None of these tables lists a glycemic index for plain peanut butter.

The index scores the carbohydrate, not the serving. The glycemic load does both: the glycemic index multiplied by the grams of carbohydrate in a serving, divided by 100 [6]. For a 1.8 oz (50 g) serving of peanuts the tables give 0 to 2 [3] [6]. For a 1 oz (30 g) slice of white bread, averaged over 16 tests, they give 11 [6].

Two cautions. None of these peanut tests is large, and the 2008 tables keep only the South African one in their main list [6]; the University of Sydney’s database marks every peanut value as coming from a test that departed from the standard method or showed wide variability [5]. All five still came out low, from 5 to 23 [3] [5]. And the tables list no glycemic index for plain peanut butter; its entries are snack bars and bread spread with it [6] [5].

What happens when you eat peanuts with a carb-heavy meal?

This is the test for peanuts eaten with other food, and the small studies of it mostly point one way. In a 2019 pilot study, 16 healthy adults ate two slices of white bread and a glass of apple juice, 60 g of carbohydrate, on one morning, and the same with 2 tablespoons (32 g) of peanut butter on another; the peak rise in blood sugar was 35.8 mg/dL with the peanut butter against 51.0 without it [7]. Every volunteer had the plain meal first, so the order was not randomised [7]. In 2005, adding peanut products to a bagel and juice cut the rise over the first hour by about 55% in 11 adults, and the cut was significant only for that meal, the one with the higher glycemic load, not for a chicken and rice one [8]. In 1984, butter or cheese added to bread did little to the rise in volunteers with type 2 diabetes, but peanut butter reduced it, in tests the 2002 tables list as run in a separate group of 6 people with type 1 diabetes [9] [3].

A randomised test that followed blood sugar from breakfast through lunch found less. In 2013, 15 Brazilian women with obesity ate a breakfast holding 75 g of carbohydrate with 1.5 oz (42.5 g) of peanuts, the same of peanut butter, or neither, on separate mornings in random order [10]. Over the four hours after breakfast, the rise in blood sugar did not differ significantly between the three; it was lower with peanut butter at 15 minutes [10]. After a standard lunch that followed, it was significantly lower on the peanut butter day [10]. In a 2013 American test, blood sugar was higher an hour after a grain bar than after peanuts, but over the two hours after the meal that followed, the totals did not differ [11]; and in 15 overweight men given a high-fat shake with 3 oz (85 g) of ground peanuts or a matched shake without them, glucose responses were similar [12].

One study points the other way, and it matters for the “spike” people report hours later. In 1987 a study found that a breakfast with fat in it, whether the fat was butter or peanut butter, worsened the blood sugar response to a standard lunch four hours later, against a breakfast with the same carbohydrate and protein but without the fat [13]. That is the opposite of the 2013 Brazilian result after lunch [10]. Both are small, and we read the 1987 study as its summary only.

Do peanuts raise blood sugar over weeks?

This is the test of the claim as most people mean it, and it has been run. A 2022 pooling, a meta-analysis that combines trials to get one estimate, gathered eight randomised trials that measured fasting blood sugar, the reading taken before breakfast [4]. With peanuts it averaged 0.03 mmol/L higher than on the comparison diets, about 0.5 mg/dL by our conversion, with a confidence interval, the range the true average probably sits in, from about 1.3 mg/dL lower to 2.5 higher [4]. No difference at all is inside that range, and so is a very small one either way. For scale, the line for diabetes on a fasting test is 126 mg/dL (7.0 mmol/L), as our statins verdict sets out.

Fasting blood sugar with peanuts, against the comparison diet: the eight trials in the 2022 pooling
TrialWhat the comparison group ateFasting blood sugar with peanuts, mg/dL
2014, 65 Brazilian men with overweight or obesity, 4 weeks [4] [14]A calorie-cut diet without peanutsAbout 0.7 higher (0.04); range 3.8 lower to 5.2 higher
2022, 63 young Spanish adults, 6 months (ARISTOTLE) [4]A butter made from peanut oil, on top of their usual foodAbout 3.2 higher (0.18) in the chart; range 5.8 lower to 12.3 higher. From the trial’s own table, about 0.5 higher (0.03), by our arithmetic
2015, 61 Australians, average age 65, 12 weeks on each diet [4]A nut-free dietAbout even (0.00); range 5.0 lower to 5.0 higher
2009, 25 young Swedish adults, 2 weeks of overeating [4]Candy, same caloriesAbout even (0.00); range 5.0 lower to 5.0 higher
2018, 25 Chinese adults with type 2 diabetes, 3 months [4]AlmondsAbout 0.7 higher (0.04) in the chart; range 6.5 lower to 7.9 higher. From the paper’s figures, about 8.5 lower to 10.0 higher, by our arithmetic
2013, 39 US adults, 8 weeks [4]A grain bar before the evening mealAbout 6.8 lower (-0.38); range 18.2 lower to 4.5 higher
2021, 223 Chinese adults with or near the metabolic syndrome, 12 weeks [4]White rice snack bars, same caloriesAbout 1.1 higher (0.06); range 2.0 lower to 4.1 higher
2014, 57 US adults with type 2 diabetes, 24 weeks [4]A peanut-free diabetes meal planAbout 5.9 higher (0.33); range 9.0 lower to 20.9 higher
All eight, pooled: 558 people [4]About 0.5 higher (0.03); range 1.3 lower to 2.5 higher
The mg/dL figures are our conversion of the pooling’s chart, which gives mmol/L, in brackets. Each range is a confidence interval, the range the true average probably sits in; it is not a range of what will happen to you. The chart enters some trials as the blood sugar people ended on and some as how far it moved. For the 2013 trial, its figures match the paper’s follow-up eight weeks after the trial ended, by our reading. We read the 2009 Swedish trial as its summary only. The 2014 Brazilian trial’s report of its blood sugar results we read in full, and the chart’s row matches it, by our arithmetic. Two rows do not match their trials’ own papers, by our reading. The chart has the control group of the six-month Spanish trial falling; the trial’s own table has it rising, from 4.47 to 4.58 mmol/L, and by that table blood sugar rose about 0.5 mg/dL more in the peanut groups than in the control group, by our arithmetic, not 3.2. For the 2018 Chinese trial, the chart enters the almond group’s figure for how precisely its average was measured as if it were the spread between people, which makes that row’s range look narrower than it was: from the paper’s figures it runs from about 8.5 lower to 10.0 higher, by our arithmetic. With both rows re-entered, keeping the chart’s spread for the Spanish trial, whose table gives none for the change, the pooled figure stays at about 0.5 mg/dL, with a range from about 1.4 lower to 2.4 higher against the chart’s 1.3 lower to 2.5 higher, by our arithmetic.

Before printing a pooled figure we look for the biggest study inside it. Here it is a 12-week Chinese trial that gave 224 adults (223 in the pooling’s chart) with or near the metabolic syndrome 2 oz (56 g) of peanuts or white rice bars as a daily snack: 36.9% of the pooling’s weight, and a difference of about 1.1 mg/dL higher on peanuts, with a range from 2.0 lower to 4.1 higher, by our conversion [4]. Its own authors found that peanuts in place of the rice bars did not significantly change fasting glucose [15].

Two trials lean towards the worry, and we report them. In the 24-week American trial of 60 adults with type 2 diabetes, the peanut group’s HbA1c, a blood test that reads your average blood sugar over the past three months, ended at 6.71% against 6.53% on the peanut-free plan, and fasting blood sugar at about 117 mg/dL against 111 (6.49 and 6.16 mmol/L) [16]. Neither difference cleared chance: the P values were 0.38 and 0.48, nowhere near the line researchers use for “probably not chance” [16]. By our arithmetic from the ranges the paper gives for each group, the HbA1c difference could lie anywhere from about 0.2 points lower to 0.6 higher: the trial was too small to show a rise, or to rule out one of about half a point [16]. The peanut butter that trial handed out had added salt and oil [16]. And in the six-month Spanish trial, fasting blood sugar went from about 82 to 86 mg/dL in the group eating peanuts (4.54 to 4.76 mmol/L), a rise short of that line against where the group started (P = 0.087); the peanut butter group went from about 83 to 84 and the control butter group from about 81 to 83, and neither peanut group was significantly different from the control group (P = 0.266) [4]. The pooling’s chart, in the table above, enters this trial with the control group’s blood sugar falling rather than rising, and so with a bigger gap; from the trial’s own table, blood sugar rose about 0.5 mg/dL more in the peanut groups than in the control group, by our arithmetic [4].

Newer trials, not in that pooling, agree with it. In 50 American adults whose fasting blood sugar was already around 100 mg/dL, 1 oz (28 g) of unsalted dry-roasted peanuts as a bedtime snack, and a snack of crackers and cheese with the same calories, each for six weeks in random order, left fasting blood sugar 0.6 mg/dL lower on the peanuts, with a range from 2.7 lower to 1.6 higher [17]. In a six-month Australian trial, 107 adults at risk of type 2 diabetes were randomised to a calorie-cut diet with 1.2 oz (35 g) of lightly salted peanuts before two meals a day, or a low-fat calorie-cut diet; 44 and 32 came to the last visit [18]. Fasting blood sugar fell in both, from about 92 to 90 mg/dL on peanuts and 92 to 88 on the low-fat diet (5.12 to 4.99 and 5.13 to 4.90 mmol/L), and HbA1c from 5.61% to 5.48% and 5.49%; the diets could not be told apart on either [18].

Wider poolings point the same way. A 2019 review of 40 trials of tree nuts and peanuts, 2,832 people, found fasting blood sugar 0.52 mg/dL lower with nuts, with a range from 1.43 lower to 0.38 higher, and HbA1c 0.02 points higher, from 0.01 lower to 0.04 higher [19]. It found fasting insulin, the hormone that moves sugar out of the blood, a little lower with nuts, and in its split by kind of nut, the four peanut trials came out like almonds, cashews and walnuts on fasting blood sugar [19]. The peanut figures sit in supplementary tables we could not retrieve. A 2020 pooling of 13 peanut trials found fasting blood sugar 0.57 mg/dL higher, with a P value of 0.604; we read it as its summary [20]. In the 2022 pooling, the four trials that measured insulin could not be separated from the comparison diets either [4]; the one with most of the weight, a two-week Swedish trial of overeating, is titled “Two weeks of overfeeding with candy, but not peanuts, increases insulin levels and body weight” [21].

One trial found a difference against peanuts. In 2013, 44 American adults ate 1 oz (28 g) of peanuts or a grain bar an hour before the evening meal for eight weeks: HbA1c fell 0.25 points on the grain bar and 0.18 on peanuts, a significant difference, though the peanut group had started higher, and eight weeks after the trial ended the gap was no longer significant [11]. The newest trial we found, of 31 older Dutch adults eating 2.1 oz (60 g) of unsalted peanuts a day for 16 weeks, reports no shift in fasting markers of blood sugar control between the two periods; we read it as its summary [22].

Who paid? Of the 14 studies on this page whose funding statements we read, ten had money, peanuts or a research partnership from industry. Eight had them from peanut industry bodies or a peanut company [11] [12] [4] [15] [16] [17] [18] [23]; in one, the paper says the funder “participated in protocol design and data discussions” [11]. The ninth is the 1981 test, whose peanuts a snack company supplied, though a diabetes charity and a government research council paid for it [2]. The tenth is the 2014 Brazilian trial, whose peanuts a Brazilian peanut company and a state agricultural research institute donated, though a US government peanut research programme and two Brazilian government research agencies paid for it [14]. Two more were paid for, at least in part, by the same US government programme [10] [24]. The newest trial, whose funding statement we could not read, lists a peanut industry research foundation as a collaborator in its registry record [22]. The ones paid for from outside the industry, by a Chinese city’s science programme [25] and a university award [7], found what the others found.

Are peanuts a good choice for people with diabetes?

For blood sugar, neither trial in people with type 2 diabetes found a significant difference between peanuts and what they replaced, though on HbA1c both leaned the worrying way. In the 24-week trial above, HbA1c and fasting blood sugar could not be told apart from the peanut-free plan, in a trial too small to rule out a rise in HbA1c of about half a point [16]. In a three-month Chinese trial, 32 adults with type 2 diabetes on a lower-carbohydrate diet swapped some of their staple food for about 2 oz (60 g) of peanuts a day for men and 1.8 oz (50 g) for women, or a similar amount of almonds; 25 finished [25]. Fasting and after-meal blood sugar fell from where they started in both groups, and the difference between the groups was not significant; HbA1c fell from where it started only in the almond group, which had started higher (7.39% against 6.81%), and at three months, adjusted for where each group started, it was 6.97% on peanuts against 6.65% on almonds, a difference the paper reports as not significant [25]. Those falls came with a diet that cut starchy food, so they cannot be credited to the nuts.

Whether peanuts fit your own plan, and in what amount, is a question for your clinician or dietitian. A handful carries calories as well as carbohydrate, and in the 2022 pooling, adults with or at risk of the metabolic syndrome given peanuts ended about 2.1 lb (0.97 kg) heavier than the comparison groups, in six trials [4].

Does peanut butter raise blood sugar more than peanuts?

Plain peanut butter, not by much. USDA’s reference entry for smooth peanut butter without salt gives 22.3 g of carbohydrate per 100 g, of which 5.0 g is fibre; for dry-roasted peanuts without salt, 21.3 g, of which 8.4 g is fibre [26]. That is about 7.1 g of carbohydrate in 2 tablespoons (32 g) of peanut butter, by our arithmetic [26]. The sugars differ more: 10.5 g per 100 g in the peanut butter entry against 4.9 g in the dry-roasted peanuts, and USDA does not say how much of the peanut butter’s was added [26]. In the Brazilian breakfast study, peanut butter did a little more than whole peanuts to lower blood sugar after lunch, which its authors put down to the fat in peanut butter being easier for the body to get at [10].

The jar to check is the reduced-fat kind. USDA’s entry for smooth reduced-fat peanut butter gives 35.6 g of carbohydrate per 100 g, against 22.3 g in the regular smooth entry, and 540 mg of sodium [26]. In its serving of 2 tablespoons (36 g), that is about 12.8 g of carbohydrate, by our arithmetic [26]. Peanut butter made to the US standard may contain added seasonings and stabilisers of no more than 10% of its weight in all, and no artificial sweeteners [27]; sugar, where a jar has it, counts inside that 10%, by our reading, and in 2 tablespoons the 10% caps everything added at 3.2 g, by our arithmetic. That cap does not bind a reduced-fat jar, which comes under one of two other federal rules. A jar called “reduced fat peanut butter” may depart from the standard only as far as it needs to make the claim and still work like the regular food, using added ingredients to improve texture or add sweetness, among other purposes; it may still not add artificial sweeteners, by our reading, and it must mark with an asterisk, in its ingredient list, anything not in the regular food or used beyond the regular food’s limit [27]. Some reduced-fat jars are called a “spread” instead [26]. A spreadable peanut product that does not meet the peanut butter standard, and is more than 10% other ingredients, must be called a peanut spread and say what share of it, by weight, is peanuts; that rule sets no limit on what is added and asks for no asterisks, though a spread short of peanut butter’s protein and certain vitamins and minerals must be labelled an imitation [27]. So a spread with no asterisks may still have had sugar added. On either kind of jar, the ingredient list shows what was added, and the Nutrition Facts label gives the grams of carbohydrate and of added sugars in a serving [27]. We do not recommend brands.

Do salted or honey-roasted peanuts raise blood sugar?

Salt adds sodium, not carbohydrate. USDA’s entries for the same Spanish peanuts, oil-roasted with and without salt, both give 17.4 g of carbohydrate per 100 g; the salted ones carry 433 mg of sodium against 6 mg [26]. Salt is a blood pressure question, and our blood pressure verdict covers what lowers it.

Flavours have been tested once that we found. In a 12-week trial, 151 adults without diabetes ate 1.5 oz (42 g) of peanuts a day, salted, unsalted, honey-roasted, spicy, or a mix; their fasting blood sugar and insulin were not significantly different after 12 weeks, and the authors report that the flavour eaten did not affect them [24]. The honey-roasted kind added only about 6 g of sugar a day, the authors note [24]. Two limits: everyone in the trial ate peanuts, so there was no group without them, and it measured blood sugar before breakfast, not after the peanuts [24].

Does roasting peanuts change their effect on blood sugar?

In the two small tests we found, roasting did not raise it. In 2011, 13 healthy Brazilian adults ate 2.2 oz (63 g) of raw peanuts with their skins, roasted peanuts, ground roasted peanuts, or a cheese sandwich with the same carbohydrate, on separate mornings; over two hours, blood sugar rose less after the ground roasted peanuts than after the raw ones [28]. A US trial registered to compare dry-roasted with boiled peanuts stopped in March 2020 with 24 people enrolled, when the pandemic halted it [29]. Two of the researchers named on its registry record reported a test of the same question in July 2026, as a conference abstract. Between 14 and 17 people drank a glucose drink on its own, then with roasted peanuts and with boiled peanuts, and again after two weeks of eating each kind every day. None of the four peanut tests left blood sugar different from the drink alone by more than chance would explain, and the authors conclude that the two kinds appear to act alike [32]. An abstract is a summary, not the full paper: it gives no comparison of the two kinds in numbers, and it does not say how the order of the tests was decided.

Do peanuts raise triglycerides?

Not in the trials, which point the other way. Our peanut butter and cholesterol verdict rates it, and finds that peanuts and peanut butter lower triglycerides, a fat carried in the blood, a little: Supported. LDL cholesterol there came out about even, and the foods that do lower it have their own verdict.

Do peanuts cause inflammation?

This page does not rate it. Of the trials here, the 12-week Australian crossover measured C-reactive protein, a blood marker of inflammation, and found 2.1 mg/L on peanuts against 2.3 off them, a difference well within chance (P = 0.620) [23].

What is the difference between a groundnut and a peanut?

None: they are the same plant, Arachis hypogaea, and the University of Sydney’s database files its Philippine tests under “Peanuts/Groundnuts” [5]. Botanically a peanut is a legume, a relative of beans, not a tree nut; the 2019 review above included peanuts anyway, because people eat them the way they eat nuts [19].

Who these studies were done on

A wide spread of people, mostly in small numbers. The trials included adults with type 2 diabetes in the US and China [16] [25], adults with raised fasting blood sugar or at risk of diabetes in the US and Australia [17] [18], Chinese adults with or near the metabolic syndrome [15], Australians averaging 65 years of age [23], young Spanish adults [4] and older Dutch adults [22]. The glycemic index tests were in healthy volunteers, apart from part of the Mexican one and one of the Philippine ones [3] [5]. No trial on this page was in children.

On women, since it is one of the searches people run: the Brazilian breakfast study was entirely women with obesity [10], about two-thirds of the six-month Australian trial were women, and that trial found no sign that fasting blood sugar responded differently in men and women [18]. If you take insulin or a medicine that lowers blood sugar, the trials do not tell you how to adjust it around a meal with peanuts; that is your clinician’s call.

If peanuts barely move blood sugar, why do some people see a spike?

This section is the desk’s own reasoning, and it is labelled as such. The tests say peanuts on their own move blood sugar very little. Some people with a glucose meter are sure they saw a jump after eating them, and the forum thread that Google’s AI answer cites asks exactly why [1]. Here are two ways those fit together, each rated.

Answer one: the jar and the plate. Reduced-fat peanut butter carries about 60% more carbohydrate, gram for gram, than the regular kind [26]; a regular jar may add sugar within its 10% allowance, and a reduced-fat one is not held to it [27]; and peanut butter on white bread brings the bread with it, which the tables score at 75 against the peanut’s 14 [3] [6]. The figures are measured. That they explain most of the spikes people report is our inference.

Answer two: the rise may come later, at the next meal. In the 1987 study, a breakfast with fat in it, peanut butter included, worsened the blood sugar response to lunch four hours later [13]; in the 2013 study, peanut butter at breakfast lowered the response to lunch [10]. Two small studies that disagree; that a late rise hours after a large, fatty snack is what some people see is a surmise, and the AI answer’s own line about a “delayed blood sugar response” comes from forum posts, not a trial [1].

Put the two together and here is what we think is true, stated plainly so you can disagree with it: on their own, peanuts barely move blood sugar; when a reading jumps after peanuts, look first at what came with them, in the jar or on the plate.

What we could not find, and would like to: a trial that measured blood sugar after people ate sweetened peanut butter or honey-roasted peanuts against the plain kind; the flavourings trial measured only the morning reading [24] [29]. And a randomised trial lasting a year or more in people with type 2 diabetes that measured HbA1c: the longest we found ran six months [18] [29]. Two registered trials will measure HbA1c in people with prediabetes, one over six months, now recruiting, and one over 12 weeks, not yet started [29]. If you know of the trials we describe, the corrections line on this site is open.

Where “peanuts raise blood sugar” came from

We could not trace who first said peanuts raise blood sugar. It turns up as a question: the forum thread asking why peanuts spike it, and related searches about salted and roasted peanuts [1]. The raw material is real enough: peanuts hold some carbohydrate, and the health-information pages that answer this search warn, fairly, that some peanut butters and peanut snacks add sugar and salt [1] [26].

The other answer has a traceable number. The 1981 test gave 13 [2], and the 2002 tables averaged it with two others to 14 [3]. The peanut promotion board’s page now says “Peanuts and peanut butter have a low glycemic index”, of “just 14”, though the tables give no figure for plain peanut butter [1] [6]. Health-information pages first published in 2017 and 2019, and updated in 2025 and 2026, repeat 13; one adds that peanuts or peanut butter in the morning may help manage blood sugar through the day, a claim the industry’s research body credits to the 15-woman breakfast study [1] [10].

And it sells. On 10 November 2020 the peanut industry’s research body put out a press release headed “Recent Research Shows Peanuts Help Control Glucose Levels”, saying that people with elevated fasting blood sugar who ate about an ounce of peanuts as an evening snack “had improved blood sugar levels in the morning” [30]. It cited a conference abstract of the bedtime-snack trial [30]. That abstract reports fasting blood sugar not significantly different from where people started after either snack; only in a subgroup picked after the fact did it fall, and it fell on the crackers and cheese as well as on the peanuts [31]. The finished trial, paid for by the same body, found the two snacks about even [17]. The research body’s diabetes page tells readers that in the peanut and almond trial “both groups showed improvement in hemoglobin A1c levels” [1]; the trial reports HbA1c falling from where it started only in the almond group [25]. A telehealth app’s blog, also cited by the AI answer, ends its answer with an invitation to book a consultation [1].

None of this is aimed at anyone checking a meter after a snack. Wanting to know what a food does to your blood sugar is the right question, and a reading that jumps deserves a look. It is the sellers on both sides who turned a small, steady result into a scare or a superfood.

What this is rated, and what the rating covers

Unsupported, of the tested kind — for the claim that peanuts and peanut butter raise blood sugar, as a spike after eating or as higher fasting blood sugar over weeks.

It was tested, and it did not hold up, for a spike after eating and for fasting blood sugar over weeks; HbA1c, the three-month reading, we rate on its own below, in people with diabetes and without, because there the trials are too small or too mixed to say as much. In the literal sense any food with carbohydrate raises blood sugar a little, and peanuts do too: in the glycemic index tests the rise ran from about a twentieth to under a quarter of glucose’s, about a seventh on the tables’ average [2] [3] [5]. The claim as it circulates is that they raise it enough to matter, as a spike after eating or as higher fasting blood sugar or HbA1c over weeks; this rating covers the first two. Every glycemic index test of peanuts we found came out low [3] [5]; in the 2022 pooling, fasting blood sugar with peanuts was about 0.5 mg/dL higher, a range that includes no difference and does not stretch to an average rise of more than about 2.5 mg/dL [4]; and the newer trials, in people with raised blood sugar or at risk of diabetes, agree [17] [18]. Findings lean the other way too, and we report them: HbA1c ended 0.18 points higher in the 24-week diabetes trial, within chance, though that trial was too small to rule out a rise of about half a point [16]; in the three-month diabetes trial against almonds, it ended 6.97% on peanuts against 6.65%, adjusted, a difference the paper reports as not significant [25]; one eight-week trial found HbA1c falling less on peanuts than on a grain bar [11]; and one 1987 study found a breakfast with fat, peanut butter or butter, left blood sugar higher after lunch [13]. The trials are mostly small and short, the longest we found six months, and most were paid for by the peanut industry.

One part of the claim, rated alone, in words. That peanuts raise HbA1c: Preliminary, in people with diabetes and in people without, for different reasons. In people with diabetes the trials are too small. One 24-week trial of 60 people found it 0.18 points higher on peanuts, within chance, and by our arithmetic its result allows anything from about 0.2 points lower to 0.6 higher [16]; a three-month trial against almonds, which 25 people finished, leaned the same way, also not significantly [25]. Neither is large enough to show a rise, or to rule one out. In people without diabetes the results are small and mixed. In the eight-week American trial, HbA1c fell less on peanuts than on a grain bar, a gap no longer significant eight weeks after the trial ended [11]; in the six-month Australian trial, the diets could not be told apart on it [18]; and across the 2019 nut pooling’s trials of healthy people, HbA1c came out 0.03 points higher with nuts, from 0.01 to 0.06 higher, a rise seen in its trials shorter than three months and not in its longer ones, where the difference was 0.001 points [19]. A completed US trial of 80 adults that listed HbA1c among its main measures has posted no results, and we found no report of it [29].

The reverse claims, rated alone, in words. That peanuts lower fasting blood sugar or HbA1c over weeks: also Unsupported, of the tested kind; the poolings could not separate peanuts from the comparison diets [4] [19] [20]. That peanuts or peanut butter blunt the rise in blood sugar from a carbohydrate meal they are eaten with: Preliminary, on small single-meal studies, one of them not randomised. Four found a smaller rise with peanuts or peanut butter, at that meal or the next [7] [8] [9] [10]; three found no significant difference over the meal itself: the breakfast of the study that followed blood sugar through to lunch [10], the 2013 test whose two-hour totals did not differ (P = 0.901) [11] and the 2017 shake test, whose responses were similar [12]; and one found the next meal’s rise larger after a breakfast with fat [13].

What is not rated here: diabetes risk in the long run, which this page did not examine; inflammation; cholesterol and triglycerides, rated on our peanut butter verdict; weight; allergy; and the frame in the section above, which is this desk’s reasoning from the evidence rather than a result the evidence delivered. It is marked as ours so that you can weigh it as ours.

This is journalism, not medical advice. If you have diabetes or prediabetes, or take a medicine that lowers blood sugar, plan changes to what you eat with your clinician or dietitian. How we read a study, and what each tier means, is set out here.

Sources
[1] Search data from a paid keyword database: the monthly US search volume for “do peanuts raise blood sugar”, and Google’s results, People Also Ask questions, related searches and AI answer for the same phrase, all pulled 20 October 2026. Pages the AI answer cites, read on 20 October 2026: the peanut promotion board’s “Diabetes and Peanuts” (15 August 2023, updated 18 May 2026); two pages of the peanut industry’s research body (7 November 2018, updated 12 April 2023; 6 February 2019, updated 23 October 2025); two health-information sites’ pages (24 October 2017, updated 23 January 2026; 16 April 2019, updated 22 December 2025); a Vietnamese hospital group’s blog (16 July 2025); a telehealth app’s blog (17 April 2025). A diabetes forum thread and a video are quoted by their titles as Google showed them; we did not open them. Kept with this page’s records.
[2] Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV. Glycemic index of foods: a physiological basis for carbohydrate exchange. American Journal of Clinical Nutrition 1981;34(3):362–366. 62 foods, each eaten by 5 to 10 healthy volunteers; peanuts by 5. Read in full in the Internet Archive’s copy of the journal’s PDF (November 2015). Supported by the British Diabetic Association and the Medical Research Council; the authors thank a snack company for providing the peanuts. doi:10.1093/ajcn/34.3.362
[3] Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. American Journal of Clinical Nutrition 2002;76(1):5–56. Read in part: its peanut, nut and bread rows, in the Internet Archive’s copy of the journal’s PDF (January 2018). Its 52 pages, searched by text, print no funding or conflict statement; the authors give the University of Sydney. doi:10.1093/ajcn/76.1.5
[4] Parilli-Moser I, Hurtado-Barroso S, Guasch-Ferré M, Lamuela-Raventós RM. Effect of peanut consumption on cardiovascular risk factors: a randomized clinical trial and meta-analysis. Frontiers in Nutrition 2022;9:853378. The ARISTOTLE trial (90 randomised, 63 finished) and a pooling of 11 trials, 8 of which measured fasting blood sugar. Read in full on PubMed Central, with its chart of the pooled glucose and insulin results from PubMed Central’s open-data store. Funded by the peanut industry’s research body and Spanish government research funds, none of which, the paper says, had a role; one author reports lecture fees from a brewers’ association and lecture fees and travel support from a foundation. doi:10.3389/fnut.2022.853378
[5] University of Sydney, Glycemic Index Research and GI News: GI Search database, searched for “peanut” and read in full on 20 October 2026. It lists the three peanut tests in the tables and two of boiled peanuts from the Philippines, as “Peanuts/Groundnuts (Arachis hypogaea L.)”, and marks every peanut value as determined with method deviations from the international standard or showing wide variability. A database; no DOI.
[6] Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008;31(12):2281–2283. Over 2,480 entries in two tables, the second for values from people with impaired glucose tolerance, small numbers of people or wide variability. The paper read in full on PubMed Central, and its peanut, peanut butter and bread rows in its online appendix, from PubMed Central’s open-data store. We found no funding statement; one author directs a not-for-profit food endorsement programme based on the glycemic index and another manages the University of Sydney’s glycemic index testing service. The 2021 edition of the tables was not read: the publisher’s page refused our requests and the Internet Archive’s copy is a bot check. doi:10.2337/dc08-1239
[7] Lilly LN, Heiss CJ, Maragoudakis SF, Braden KL, Smith SE. The effect of added peanut butter on the glycemic response to a high-glycemic index meal: a pilot study. Journal of the American College of Nutrition 2019;38(4):351–357. 16 healthy adults. Read as its published abstract, with its funding note in the Internet Archive’s copy of the publisher’s page (January 2025): a faculty research award from the authors’ university. doi:10.1080/07315724.2018.1519404
[8] Johnston CS, Buller AJ. Vinegar and peanut products as complementary foods to reduce postprandial glycemia. Journal of the American Dietetic Association 2005;105(12):1939–1942. 11 healthy adults. Read as its published abstract; its funding statement was not read. doi:10.1016/j.jada.2005.07.012
[9] Jenkins DJ, Wolever TM, Wong GS, Kenshole A, Josse RG, Thompson LU, Lam KY. Glycemic responses to foods: possible differences between insulin-dependent and noninsulin-dependent diabetics. American Journal of Clinical Nutrition 1984;40(5):971–981. Read as its published abstract; its funding statement was not read. doi:10.1093/ajcn/40.5.971
[10] Reis CE, Ribeiro DN, Costa NM, Bressan J, Alfenas RC, Mattes RD. Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: a randomised cross-over clinical trial. British Journal of Nutrition 2013;109(11):2015–2023. 15 women. Read in full in the publisher’s open PDF. Supported by Brazilian government research agencies and the US Agency for International Development through its peanut research programme; the authors declare no conflict of interest. doi:10.1017/S0007114512004217
[11] Johnston CS, Trier CM, Fleming KR. The effect of peanut and grain bar preloads on postmeal satiety, glycemia, and weight loss in healthy individuals: an acute and a chronic randomized intervention trial. Nutrition Journal 2013;12:35. 15 adults in the one-meal test, 44 in the 8-week trial. Read in full on PubMed Central. Supported by a US peanut promotion board, which, the paper says, “participated in protocol design and data discussions”; the first author reports reimbursements and funding from peanut and almond industry bodies. doi:10.1186/1475-2891-12-35
[12] Liu X, Hill AM, West SG, Gabauer RM, McCrea CE, Fleming JA, Kris-Etherton PM. Acute peanut consumption alters postprandial lipids and vascular responses in healthy overweight or obese men. Journal of Nutrition 2017;147(5):835–840. 15 men. Read in full on PubMed Central. Supported by the peanut industry’s research body and US National Institutes of Health grants; two authors report funding or advisory roles with other food industry bodies. doi:10.3945/jn.116.246785
[13] Collier GR, Wolever TM, Jenkins DJ. Concurrent ingestion of fat and reduction in starch content impairs carbohydrate tolerance to subsequent meals. American Journal of Clinical Nutrition 1987;45(5):963–969. Read as its published abstract, which does not give the number of volunteers; its funding statement was not read. doi:10.1093/ajcn/45.5.963
[14] Moreira Alves RD, Boroni Moreira AP, Macedo VS, Bressan J, de Cássia Gonçalves Alfenas R, Mattes R, Brunoro Costa NM. High-oleic peanuts: new perspective to attenuate glucose homeostasis disruption and inflammation related obesity. Obesity 2014;22(9):1981–1988. The 2014 Brazilian trial’s report of its blood sugar results: 65 men with overweight or obesity, 4 weeks. Read in full in the Internet Archive’s copy of the publisher’s page (November 2020). Supported by two Brazilian government research agencies (CNPq and CAPES) and the Peanut Collaborative Research Support Program, a US Agency for International Development programme; the authors thank a Brazilian state agricultural research institute (Instituto Agronômico de Campinas) and a Brazilian peanut processing company (CAP Agroindustrial) for donating the peanuts. This report prints no conflict statement; the trial’s report on body composition (Obesity 2014;22(6):1422–1429) names the same funders and says the authors have nothing to disclose. doi:10.1002/oby.20825
[15] Wang D, Sun L, Liu X, et al. Replacing white rice bars with peanuts as snacks in the habitual diet improves metabolic syndrome risk among Chinese adults: a randomized controlled trial. American Journal of Clinical Nutrition 2021;113(1):28–35. 224 adults. Read as its published abstract and funding note, in the Internet Archive’s copy of the publisher’s page (April 2024); its glucose result is as the 2022 pooling’s chart gives it. Funded by Chinese government science grants, with funding and the peanuts from the peanut industry’s research body and a US peanut promotion board; the rice bars were made by a health-technology company that is one author’s affiliation; the paper says no funder had a role. doi:10.1093/ajcn/nqaa307
[16] Wien M, Oda K, Sabaté J. A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes. Nutrition Journal 2014;13:10. 60 adults randomised, 57 finished. Read in full on PubMed Central. Funded by a US peanut promotion board, which the paper says had no role; the authors declare no conflicts. doi:10.1186/1475-2891-13-10
[17] Sapp PA, Kris-Etherton PM, Petersen KS. Peanuts or an isocaloric lower fat, higher carbohydrate nighttime snack have similar effects on fasting glucose in adults with elevated fasting glucose concentrations: a 6-week randomized crossover trial. Journal of Nutrition 2022;152(1):153–162. 50 adults. Read in full on PubMed Central. Supported by the peanut industry’s research body, which gave two of the authors a grant for the research, and a US National Institutes of Health award. doi:10.1093/jn/nxab347
[18] Petersen KS, Murphy J, Whitbread J, Clifton PM, Keogh JB. The effect of a peanut-enriched weight loss diet compared to a low-fat weight loss diet on body weight, blood pressure, and glycemic control: a randomized controlled trial. Nutrients 2022;14(14):2986. 107 adults randomised. Read in full on PubMed Central. Funded by the peanut industry’s research body, which gave three of the authors the grant and which, the paper says, had no role. doi:10.3390/nu14142986
[19] Tindall AM, Johnston EA, Kris-Etherton PM, Petersen KS. The effect of nuts on markers of glycemic control: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2019;109(2):297–314. 40 trials, 2,832 people; 4 of the trials were of peanuts. Read in full on PubMed Central, apart from its supplementary tables, which hold the figures for each kind of nut: PubMed Central served a download page we could not get past by request. The paper says it received no funding; one author had research funding from a walnut growers’ commission. doi:10.1093/ajcn/nqy236
[20] Jafari Azad B, Daneshzad E, Azadbakht L. Peanut and cardiovascular disease risk factors: a systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition 2020;60(7):1123–1140. 13 trials, some of them of peanut oil or a peanut-sprout extract rather than peanuts. Read as its published abstract, with its funding and conflict statements read in the Internet Archive’s copy of the publisher’s page (March 2024): supported by a grant from a medical university in Tehran; the authors declare no conflict of interest. doi:10.1080/10408398.2018.1558395
[21] Claesson AL, Holm G, Ernersson A, Lindström T, Nystrom FH. Two weeks of overfeeding with candy, but not peanuts, increases insulin levels and body weight. Scandinavian Journal of Clinical and Laboratory Investigation 2009;69(5):598–605. 25 adults finished. Read as its published abstract; its glucose result is as the 2022 pooling’s chart gives it; its funding statement was not read. doi:10.1080/00365510902912754
[22] Kerkhof L, Mensink RP, Plat J, Nijssen KMR, Joris PJ. Daily consumption of unsalted, skin-roasted peanuts beneficially affects regional brain insulin responsiveness in older adults: results of a longer-term randomized controlled trial. Food & Function 2026;17(20):9354–9364. 31 older adults. Read as its published abstract: the publisher’s article page, landing page and PDF refused our requests, and neither PubMed Central nor the Internet Archive holds a copy. Its funding statement was not read. Its registry record (ClinicalTrials.gov NCT05724654, read on 20 October 2026) names a Dutch university medical centre as sponsor and a peanut industry research foundation as collaborator, and posts no results. doi:10.1039/d6fo03208g
[23] Barbour JA, Howe PRC, Buckley JD, Bryan J, Coates AM. Effect of 12 weeks high oleic peanut consumption on cardio-metabolic risk factors and body composition. Nutrients 2015;7(9):7381–7398. 61 adults. Read in full on PubMed Central. Funded by an Australian Research Council grant in partnership with an Australian peanut company, which supplied the peanuts; the authors declare no conflict. doi:10.3390/nu7095343
[24] Jones JB, Provost M, Keaver L, Breen C, Ludy MJ, Mattes RD. A randomized trial on the effects of flavorings on the health benefits of daily peanut consumption. American Journal of Clinical Nutrition 2014;99(3):490–496. 151 adults, every one of them given peanuts. Read in full in the Internet Archive’s copy of the journal’s former site (September 2017). Supported by a US Agency for International Development peanut research programme; the authors declare no conflict. doi:10.3945/ajcn.113.069401
[25] Hou YY, Ojo O, Wang LL, Wang Q, Jiang Q, Shao XY, Wang XH. A randomized controlled trial to compare the effect of peanuts and almonds on the cardio-metabolic and inflammatory parameters in patients with type 2 diabetes mellitus. Nutrients 2018;10(11):1565. 32 adults randomised, 25 finished. Read in full on PubMed Central. Funded by a Chinese city’s science and technology programme; the authors declare no conflicts. doi:10.3390/nu10111565
[26] US Department of Agriculture, FoodData Central, SR Legacy entries, all last updated 1 April 2019: “Peanuts, all types, raw” (NDB 16087), “Peanuts, all types, dry-roasted, without salt” (16390), “Peanuts, spanish, oil-roasted, with salt” (16092) and “without salt” (16392), “Peanut butter, smooth style, without salt” (16398) and “Peanut butter, smooth, reduced fat” (16150). Read through FoodData Central on 20 October 2026. For how reduced-fat jars are named, FoodData Central’s branded-food entries, searched for “reduced fat peanut butter” on 20 October 2026 (the first 50 of 306 results read): reduced-fat products named “peanut butter spread” from three brand owners appear beside others named “peanut butter”, one of them with asterisks in its ingredient list; a sample of the database, not of the shelf. Government reference entries; no DOI.
[27] US Code of Federal Regulations, 21 CFR 164.150, “Peanut butter”, the federal standard of identity, and 21 CFR 130.10, “Requirements for foods named by use of a nutrient content claim and a standardized term”, the rule for versions such as “reduced fat”; 21 CFR 102.23, “Peanut spreads”; and 21 CFR 101.9(c)(6), the carbohydrate and added sugars lines of the Nutrition Facts label; the current text of all four read on the electronic Code of Federal Regulations on 20 October 2026 (up to date as of 16 October 2026). Regulations; no DOI.
[28] Reis CE, Bordalo LA, Rocha AL, Freitas DM, da Silva MV, de Faria VC, Martino HS, Costa NM, Alfenas RC. Ground roasted peanuts leads to a lower post-prandial glycemic response than raw peanuts. Nutrición Hospitalaria 2011;26(4):745–751. 13 healthy adults. Read in full on the journal’s open site; we found no funding statement in it; its authors were at Brazilian federal universities. PubMed gives it doi:10.1590/S0212-16112011000400012, which the DOI system does not hold (checked 20 October 2026); the paper on the journal’s open site.
[29] The desk’s searches, 20 October 2026, for the absence sentences on this page. That we found no trial measuring blood sugar after sweetened peanut butter or honey-roasted peanuts against the plain kind: PubMed by title and abstract in two wordings (peanuts or nut butters with honey, sweetened or added sugar, and glucose or insulin, 30 records; peanut butter, honey-roasted or flavoured peanuts with postprandial, blood sugar or glycemic, 19 records), every title read; because neither returned the flavourings trial, a third wording that must and did return it (22 records); the wider class, nut butters, in the first wording; ClinicalTrials.gov (62 records for peanuts with blood sugar or diabetes outcomes and 18 for peanut butter with glucose or insulin, every title read); the tables of trials in the 2019 nut pooling and a 2025 review of nut trials in calorie-cut diets; and an ordinary web search, its first page read. That we found no randomised trial of a year or more of peanuts in people with type 2 diabetes measuring HbA1c: PubMed in two wordings (7 and 12 records, every title read); the wider class through the same two reviews, whose peanut trials ran 4 weeks to 6 months; the same ClinicalTrials.gov records, in which two registered trials will measure HbA1c in prediabetes (NCT06867198, recruiting, 72 people over six months; NCT07714096, not yet recruiting, 56 people in a 12-week crossover) and a trial of dry-roasted against boiled peanuts (NCT04171648) stopped in March 2020 with 24 people enrolled, its record giving the pandemic as the reason; and an ordinary web search, its first page read. Run again on 20 October 2026 by the editor who corrected this page after its first review: PubMed by title and abstract (40 records for peanut trials with blood sugar outcomes, 20 for nut or legume trials of a year or more, 31 for sweetened or flavoured peanuts, 17 for roasting, 19 for the glycemic index, every title read), ClinicalTrials.gov (48 records for peanuts with blood sugar outcomes, every title read) and two ordinary web searches, their first pages read, with the same result. For the completed US trial of peanuts and immunity that listed HbA1c among its main measures (ClinicalTrials.gov NCT06159556, sponsored by a US university, completed in September 2024 with 80 enrolled, no results posted; read on 20 October 2026): PubMed for its registry number (0 records) and for its lead investigator’s peanut papers of 2024 to 2026 (2 records, neither of them this trial), Europe PMC for its registry number (0 records) and an ordinary web search, whose first page held only registry pages. Run a third time by the desk on 20 October 2026, after publication: PubMed by title and abstract in four more wordings (sweetened, honey, coated or flavoured peanuts or nut butters with blood sugar outcomes, 84 records; peanut butter, peanut snacks or honey-roasted peanuts with after-meal or glycemic outcomes, 14; peanuts with HbA1c or glycemic control, 22; peanut trials in diabetes or prediabetes, 11; every title read), a fifth on peanut preparation and blood sugar (10 records, every title read), ClinicalTrials.gov (16 records for peanuts with diabetes, every title read) and two ordinary web searches, their first pages read. The findings on sweetened peanuts and on year-long trials held. One web search led to what the indexes had not: a July 2026 conference abstract of boiled against roasted peanuts [32], which corrected the roasting section the same day. The record is kept with this page.
[30] The peanut industry’s research body. “Recent Research Shows Peanuts Help Control Glucose Levels”, a press release on a news-release wire, Albany, Georgia, 10 November 2020. Read in full on 20 October 2026. A press release; no DOI.
[31] Sapp P, Petersen K, Kris-Etherton P. Fasting glucose response to evening snacks that differ by carbohydrate and fat composition: a 6-week, randomized, crossover trial in subjects with impaired fasting glucose. Current Developments in Nutrition 2020;4(Suppl 2):1143. A conference abstract of the same trial, 51 people. Read in full on PubMed Central. Funding sources given: the peanut industry’s research body and the US National Institutes of Health. doi:10.1093/cdn/nzaa055_028
[32] Londoño JA, Fares A, Allen JC, Dean LL. Glycemic response to boiled and roasted peanuts. Current Developments in Nutrition 2026;10(Suppl 1):107894. A conference abstract, read in full on the journal’s open site on 20 October 2026. It is not in PubMed or Europe PMC, and an OpenAlex title search returned no full paper. Funding source given: the North Carolina Agricultural Research Service. Its last two authors are named as study chair and study director on the registry record of the trial stopped in 2020 (ClinicalTrials.gov NCT04171648, North Carolina State University). doi:10.1016/j.cdnut.2026.107894
Correction · 20 October 2026

Within hours of publication, the desk’s own search found a July 2026 conference abstract in which researchers tested boiled against roasted peanuts with a glucose drink. Two of them are named on the registered trial this page had described only as stopped in 2020. The roasting section said “the one small test we found”; it now describes both tests, and the funding row and the record of searches include the new source [32]. It points the same way as the rest, and the rating is unchanged.